NEWS
TEMPUS EXPANDS COLLABORATION WITH ASTRAZENECA TO SUPPORT GUIDELINE- DIRECTED BIOMARKER TESTING IN NSCLC
Tempus , a leader in Artificial
Intelligence and precision medicine , has announced an expansion of its collaboration with AstraZeneca , which leverages Tempus Next to arm physicians with technology that supports the delivery of guidelinedirected biomarker testing for patients with non-small cell lung cancer ( NSCLC ).
Tempus Next is designed to accelerate the adoption of precision medicine and enhance patient outcomes . The solution integrates seamlessly with EMRs in order to analyse a comprehensive suite of data – including clinical notes , molecular information and imaging – to pinpoint certain deviations from care guidelines . Participating health systems receive regular updates , supporting guidelinedirected care for their patients .
The magnitude and frequency of updates to oncology guidelines each year make it difficult for the updates to be rapidly incorporated into patient treatment plans . As part of a larger , strategic collaboration , the two companies are now expanding upon a pilot programme that utilises Next , Tempus ’ care pathway intelligence platform , to help physicians determine if their patients with NSCLC may benefit from guideline-directed molecular testing , including testing for epidermal growth factor receptor ( EGFR ) mutations .
“ Next was designed to ensure all patients have access to treatment plans based on the most up-to-date guidelines by equipping physicians with cutting-edge tools in their existing workflows to support the delivery of evidence-based care ,” said Chris Scotto DiVetta , Senior Vice President , AI Applications at Tempus . “ We were excited to see initial success in this programme and look forward to contributing to a future where advanced technology and medical expertise unite to improve outcomes for all patients .”
BANK GOES LIVE WITH FINASTRA TO DELIVER TAILORED FINANCIAL SERVICES TO THE HEALTHCARE SECTOR
Finastra has announced that Bank Midwest , an employee-owned bank with locations throughout Iowa , Minnesota and South Dakota , has launched OnePlace . bank , a digital bank powered by Finastra , focused exclusively on the financial needs of the healthcare community . The move expands Bank Midwest ’ s collaboration with the financial software provider , utilising its Phoenix core solution and digital banking to go to market quickly and efficiently .
“ When we made the decision to launch OnePlace . bank , we turned to our partners at Finastra , leveraging their agile solutions and partner ecosystem to build a digital bank specifically tailored to healthcare professionals ,” said Bryan Wilken , Chief Information Operations Officer at Bank Midwest . “ We offer a personalised , tailored and consistent customer experience , and we know that our loyal customers expect the latest products and services . With Finastra ’ s platform , commitment to open finance , and expertise , we can deliver on this promise quickly and efficiently , allowing us to deliver innovative solutions and exceed customer expectations .”
Building on the bank ’ s OnePlace Capital business line , which offers unique equipment financing options tailored to meet the needs of dental , medical , and veterinary practices , the digital bank represents a natural progression for the brand . OnePlace . bank is now the virtual home of this niche loan programme , which also offers new deposit , treasury management and ancillary banking services designed specifically for healthcare professionals .
“ Digital transformation is at the foundation of our strategy of improving the convenience and efficiency of our delivery , allowing us to continue our focus on new and innovative products and services healthcare professionals need to thrive in this ever-changing marketplace ,” added Scott Stewart , President of OnePlace Capital .
www . intelligenthealth . tech 7